Fatty acyl-CoAs inhibit retinoic acid-induced apoptosis in Hep3B cells

Cancer Letters

Volumn 154, Issue 1, 2000, Pages 19-27

  Wan, Yu Jui Yvonne ^a   Cai, Yan ^a   Cowan, Catherine ^a   Magee, Thomas R ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Fatty acyl CoA; Hepatocyte nuclear factor 4; Hepatoma; Retinoic acid; Transforming growth factor

Indexed keywords

ACYL COENZYME A; HEPATOCYTE NUCLEAR FACTOR 4; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL VIABILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL;

APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FATTY ACIDS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIGANDS; LIVER NEOPLASMS; PALMITOYL COENZYME A; PHOSPHOPROTEINS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN; TUMOR CELLS, CULTURED;

BOVINAE;

EID: 0034213689     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00341-4     Document Type: Article

References (36)

1. Sporn M.B., Robers A.B., Goodman D.S. The Retinoids. 2nd Edition:1994;Raven Press, New York.
2. Muto Y., Moriwaki H., Ninomiya M., Adachi S., Saito A., Takasaki K.T., Tanaka T., Tsurumi K., Okuno M., Tomita E., Nakamura T., Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N. Engl. J. Med. 334:1996;1561-1567.
3. Nagy L., Thomazy V., Shipley G.L., Fesus L., Lamph W., Heyman R.A., Chandraratna R.A., Davies P.J. Activation of retinoid x receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:1995;3540-3551.
4. Horn R., Minucci C., Ogryzko V.V., Adamson E.D., Howard B.H., Levin A.A., Ozato K. RAR and RXR selective ligands cooperatively induce apoptosis and neural differentiation in P19 embryonal carcinoma cells. FASEB J. 10:1996;1071-1077.
5. Li Y., Hashimoto Y., Agadir A., Kagechika H., Zhang X.K. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J. Biol. Chem. 274:1999;15360-15366.
6. Kim D.G., Jo B.H., You K.R., Ahn D.S. Apoptosis induced by retinoic acid in Hep3B cells in vitro. Cancer Lett. 107:1996;149-159.
7. Nakamura N., Shidoji Y., Yamada Y., Hatakeyama H., Moriwaki H., Muto Y. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HUH-7. Biochem. Biophys. Res. Commun. 207:1995;382-388.
8. Lin J.-K., Chou C.-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res. 52:1992;385-388.
9. Fan G., Ma X., Kren B.T., Steer C.J. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene. 12:1996;1909-1919.
10. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10:1996;267-282.
11. Cereghini S., Yaniv M., Cortese R. Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. EMBO J. 9:1990;2257-2263.
12. Griffo G.B., Hamon C., Angrand P.O., Fox M., West L., Lecoq O., Povey D., Cassio D., Weiss M. HNF4 and HNF1 as well as a panel of hepatic functions are extinguished and reexpressed in parallel in chromosomally reduced rat hepatoma-human fibroblast hybrids. J. Cell Biol. 121:1993;887-898.
13. Spath G.F., Weiss M.C. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol. Cell. Biol. 17:1997;1913-1922.
14. Sladek F.M., Zhong W.M., Lai E., Darnell J.E. Liver-enriched transcription factor HNF4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:1990;2353-2365.
15. Hertz R., Magenheim J., Berman I., Bar-Tana J. Fatty acyl-CoAs thioesters are ligands of hepatic nuclear factor-4α Nature. 392:1998;512-516.
16. Mietus-Snyder M., Sladek F.M., Ginsburg G.S., Kuo C.F., Ladias J.A.A., Darnell J.E. Jr., Karathanasis S.K. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear 4 modulates apolipoprotein CIII gene expression in liver and intestine cells. Mol. Cell. Biol. 12:1992;1708-1718.
17. Nakashatri H., Chambon P. The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF4 and ARP-1 homo- and heterodimers. J. Biol. Chem. 269:1994;890-902.
18. Garcia A.D., Ostpchuk P., Hearing P. Functional interaction of nuclear factors EF-C, HNF4 and RXRα with hepatitis B virus enhancer I. J. Virol. 67:1993;3940-3950.
19. Magee T., Cai Y., Locker J., Wan Y.-J. Retinoic aid mediates down-regulation of the α-fetoprotein gene through decreased expression of hepatocyte nuclear factors. J. Biol. Chem. 273:1998;30024-30032.
20. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-chloroform extraction. Anal. Biochem. 162:1987;156-159.
21. Arrick B.A., Lopez A.R., Elfman F., Ebner R., Damsky C.H., Derynick R. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol. 118:1992;715-726.
22. Gunning P., Ponte P., Okayama H., Engel J., Blau H., Kedes L. Isolation of characterization of full length cDNA clones for human alpha-, beta-, and gamma actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3:1983;787-795.
23. Chen C., Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient system for stable transforming cells with plasmid DNA. Biotechniques. 6:1988;632-638.
24. Fulton R., Van Ness B. Luminescent reporter gene assays for luciferase and β-galactosidase using a liquid scintillation counter. Biotechniques. 14:1993;762-763.
25. Hsu S.-L., Wu W.-S., Tyan Y.S., Chou C.-K. Retinoic acid-induced apoptosis is prevented by serum albumin and enhanced by lipiodol in human hepatoma Hep3B cells. Cancer Lett. 129:1998;205-214.
26. Han G.R., Dohi D.F., Lee H.-Y., Rajah R., Walsh G.L., Hong W.K., Cohen P., Kurie J.M. All-trans-retinoic acid increases transforming growth factor-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-α-dependent signaling pathway. J. Biol. Chem. 21:1977;13711-13716.
27. Kim S.-J., Glick A., Sporn M.B., Roberts A.B. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264:1989;402-408.
28. Melino G., Draoui M., Bellincampi L., Bernassola F., Vernardini S., Piacentini M., Reichert U., Cohen P. Retinoic acid receptors α and γ mediate the induction of 'tissue' transglutaminase activity and apoptosis in human neuroblastoma cells. Exp. Cell Res. 235:1997;55-61.
29. Zhang L.-X., Mills K.-J., Dawson M.L., Collins S.J., Jetten A. Evidence for the involvement of retinoic acid receptor RAR-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem. 11:1995;6022-6029.
30. Hsu C.A., Rishi A.K., Su-Li X., Gerald T.M., Dawson M.I., Schiffer C., Reichert U., Shroot B., Poirer G.C., Fontana J.A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood. 89:1997;4470-4479.
31. Watson A. The role of fas in apoptosis induced by anticancer drugs. Hepatoma. 29:1999;280-281.
32. Imai S., Okuno M., Moriwaki H., Muto Y., Murakami K., Shudo K., Suzuki Y., Kojima S. 9,13-di-cis-retinoic acid induces the production of tPA and activation of latent TGFβ via RARα in a human liver stellate cell line, LI90. FEBS Lett. 411:1997;102-106.
33. Jiang S., Jung Song M., Shin E.-C., Lee M.-O., Kim S.J., Park J.H. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via fas-dependent and fas-independent pathways. Hepatoma. 29:1999;101-110.
34. Takeshita A., Imai K., Kato S., Kitano S., Hanazawa S. 1α,25-dehydroxyvitamin D3 synergism toward transforming factor-β1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor. J. Biol. Chem. 24:1998;14738-14744.
35. Hertz R., Berman I., Bar-Tana J. Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl-CoA derivative. Eur. J. Biochem. 221:1994;611-615.
36. DiRusso C.C., Tsvetnitsky V., Hojrup P., Knudsen J. Fatty acyl-CoAs binding domain of the transcription factor FadR. Characterization by deletion, affinity labeling, and isothermal titration calorimetry. J. Biol. Chem. 273:1998;33652-33659.